SCYNEXIS, Inc. (SCYX) Financials

SCYX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 148.5 million 56.6 million
2023-06-30 154.9 million 61.8 million
2023-03-31 70.3 million 100.2 million
2022-12-31 87.8 million 84.6 million

SCYX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 12.4 million 632000
2023-06-30 74.4 million 728000
2023-03-31 -18.9 million 707000
2022-12-31 -22.8 million 454000

SCYX Net Income

No data available :(

SCYX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 88.1 million - 3.0 million
2023-06-30 85.5 million - 3.1 million
2023-03-31 54.8 million - 3.1 million
2022-12-31 73.5 million - 3.2 million

SCYX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 47.9 million
2023-06-30 49.9 million
2023-03-31 47.8 million
2022-12-31 42.6 million

SCYX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 6.5 million 5.0 million -
2023-06-30 - 7.0 million 7.5 million -
2023-03-31 - 6.8 million 4.8 million -
2022-12-31 9000 7.8 million 16.0 million -

SCYX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.8 million 379000
2023-06-30 131.5 million 426000
2023-03-31 1.1 million 137000
2022-12-31 1.5 million 196000

SCYX

Price: $1.72

52 week price:
1.35
3.87

Earnings Per Share: 1.49 USD

P/E Ratio: 1.33

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 45800

Ebitda: -8.0 million

Market Capitalization: 60.6 million

Links: